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CASE  REPORT
Introduction
Sheehan’s syndrome is a rarely encountered disease. It
was first reported in 1937 by Sheehan et al,1 who
described a case of postpartum pituitary necrosis and
insufficiency. Most cases remain undiagnosed until
years after parturition. Sheehan’s syndrome that
presents acutely is comparatively rare. Here, we report
such a case of acute Sheehan’s syndrome complicated
with heart failure, followed by a discussion of the
manifestations of acute Sheehan’s syndrome and its
diagnosis.
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We report the case of a young woman with Sheehan’s syndrome who presented with ventricular arrhythmia and
congestive heart failure. The patient was admitted because of postpartum hemorrhage and hypovolemic shock;
a massive blood transfusion was required to restore blood volume. After initial stabilization, the patient developed
acute respiratory distress and congestive heart failure accompanied by hemodynamic instability 2 weeks after
delivery. Episodes of ventricular tachycardia of the torsade de pointes type and a prolonged QT interval were
noted on baseline electrocardiogram. A low cortisol level was found incidentally, which led to the suspicion of
hypopituitarism. The diagnosis was later supported by laboratory findings of multiple pituitary hormone deficiencies.
After administration of corticosteroids and thyroxine, the patient’s clinical condition improved dramatically. A pituitary
magnetic resonance imaging scan 32 days after delivery revealed a diminished and flattened pituitary gland with
prominent intrasellar cerebrospinal fluid loculation, which was compatible with the clinical diagnosis of empty
sella with panhypopituitarism. The syndrome of acute anterior pituitary necrosis secondary to postpartum hemorrhage
and shock was first described by Sheehan in 1939. Although the occurrence of Sheehan’s syndrome is now rare,
it should still be considered in any woman with a history of peripartum hemorrhage who develops manifestations
of pituitary hormone deficiency. Appropriate hormone replacement therapy is essential and always results in dramatic
clinical improvement. [J Chin Med Assoc 2005;68(8):386–391]
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Case Report
This case describes a 33-year-old woman without
significant past illness who had previously given birth
to 3 children via Cesarean section. All 3 deliveries were
uneventful, and the patient had normal postpartum
lactation. For this fourth pregnancy, placenta previa
was identified; therefore, at 39 weeks’ gestation, the
patient again underwent Cesarean section at the local
obstetrics clinic. However, the operation was
complicated by massive postpartum hemorrhage,
resulting in hypotension and, eventually, circulatory
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shock. After an emergency hysterectomy, the patient
was transferred to our hospital.
On arrival, the patient had a body temperature of
35°C, blood pressure of 80/40 mmHg, heart rate of
108 beats/min, and respiratory rate of 28 breaths/
min. She appeared somnolent, and her conjunctivae
were pale, but she had no scleral icterus. Her jugular
veins were collapsed. No palpable goiter or lymph
nodes were noted from neck examination. The patient’s
breathing pattern appeared normal, and her abdomen
was notable for a surgical scar. She had no lower
extremity edema, and her skin was cold and moist.
Initial laboratory findings were remarkable for the
following: white blood cell count, 17,800/μL;
hemoglobin, 6.6 g/dL; platelet count, 132,000/μL;
prothrombin time, 14.3 seconds; activated partial
thromboplastin time, 34.9 seconds; fibrinogen, 99.8
mg/dL; D-dimer, 2,878 ng/mL; plasma glucose,
197 mg/dL; blood urea nitrogen, 9.9 mg/dL; serum
creatinine, 0.8 mg/dL; sodium, 141 mmol/L;
potassium, 4.5 mmol/L. On the day of admission,
because of sustained hemorrhage and resulting
circulatory shock and respiratory failure, the patient
required endotracheal intubation and mechanical
ventilation. After resuscitation with liberal amounts of
intravenous fluids and blood transfusions, the patient’s
condition stabilized. On day 10 of hospitalization, she
was transferred out of the intensive care unit (ICU)
after successful extubation.
On postpartum day 19, the patient again developed
respiratory distress and became unconscious. Chest
radiography revealed acute pulmonary edema (Figure
1). The patient was transferred back to the ICU after
endotracheal intubation. A pulmonary perfusion scan
obtained later indicated a low probability of pulmonary
embolism. Echocardiography revealed normal heart
size but diffuse hypokinesis (left ventricular ejection
fraction was 40%). Angiotensin converting enzyme
inhibitor and diuretic therapy was administered for
heart failure. Brief episodes of polymorphic ventricular
tachyarrhythmia were detected during this period
(Figure 2A), for which amiodarone was administered.
A 12-lead electrocardiogram (ECG) showed QT-
interval prolongation, with a calculated QTc of 0.56
seconds (Figure 2B). Pertinent laboratory findings
were as follows: creatine phosphokinase (CPK), 71
U/L; CPK-MB, < 5 U/L; troponin-I, 0.4 ng/mL;
myoglobin, 39.5 U/L; sodium, 141 mmol/L;
potassium, 3.2 mmol/L; magnesium, 1.8 mmol/L;
ionized calcium, 1.02 mmol/L. On the third day of
her ICU stay, she had a seizure. A brain magnetic
resonance imaging (MRI) scan obtained afterwards
revealed no notable abnormality.
To determine the cause of the patient’s
hemodynamic instability, besides her seizure onset,
thyroid and adrenal function were assessed. Initial
hormone levels suggested hypofunction in both axes,
with a thyroid stimulating hormone level of 0.802
IU/L, free thyroxine of 0.4 ng/dL, and morning
cortisol level of 2.9 μg/dL. Linking these findings
with the patient’s history of postpartum hemorrhage,
Figure 1. Acute pulmonary edema at postpartum day 19.
Figure 2. (A) Polymorphic ventricular tachycardia of the torsade
de pointes type; (B) complete 12-lead electrocardiogram during
normal rhythm.
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and based on a high likelihood of Sheehan’s syndrome,
we decided to further evaluate pituitary function. As
subnormal levels were noted across the panel of pituitary
hormones, the diagnosis of panhypopituitarism was
established (Table 1). The patient was then promptly
given intravenous injections of hydrocortisone 100
mg 8-hourly, followed by oral thyroxine 0.05 mg/
day. Such therapeutic measures resulted in dramatic
clinical improvement. Arrhythmia did not recur during
the patient’s subsequent course. After 3 days,
mechanical ventilation was stopped and the patient
was transferred out of the ICU. The patient’s post-
ICU course was notable for excessive urine output
(> 3 L/day). However, a water deprivation test did not
confirm diabetes insipidus (Figure 3). On postpartum
day 32, a pituitary MRI scan was obtained (Figure 4).
It revealed a flattened pituitary gland and loculation of
cerebrospinal fluid within the sella turcica. These
findings were compatible with the clinical diagnosis of
empty sella with hypopituitarism. On postpartum day
37, the patient was discharged home uneventfully.
Table 1. Serum hormonal levels via radioimmunoassay at postpartum day 21
Hormones Basal value Normal value
Cortisol (morning; μg/dL) 2.9 4.3–22.4
Adrenocorticotropic hormone (pg/mL) 8.1 9–46
Free thyroxine (ng/dL) 0.4 0.89–1.76
Thyroid stimulating hormone (μIU/mL) 0.802 0.35–5.5
Prolactin (ng/mL) 12.1 > 20 (in postpartum)
Luteinizing hormone (mIU/mL) 0.9 3–9
Follicle stimulating hormone (mIU/mL) 0.5 4–9
Estradiol (pg/mL) 13.2 33–100
Growth hormone (ng/mL) 0.1 < 8.6
Figure 3. Water deprivation test.
Figure 4. Pituitary magnetic resonance imaging (MRI) scan at postpartum day 32: (A) T1-weighted coronal image; (B) T2-weighted coronal
image; (C) post Gd-DTPA enhancement of sagittal image. The pituitary gland appears more flattened than normal, with cerebrospinal fluid
loculation within the sella turcica. High signal intensity is noted in the T2-weighted image. The pituitary stalk appears deviated to the right.
No abnormal signaling is noted after contrast enhancement and no tumors are noted. Enhancement with Gd-DTPA shows no intrasellar
mass or adenoma with delayed enhancement. MRI findings are thus compatible with a clinical diagnosis of Sheehan’s syndrome.
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Discussion
During pregnancy, the pituitary gland enlarges to
twice its normal size. Because of the consequent
increase in the demand for blood supply, the gland
becomes liable to ischemic injury if blood flow is
compromised by hemorrhage, shock, or compression
of the portal vessels by the enlarged gland. The
adenohypophysis is more vulnerable than the
neurohypophysis because of its relatively smaller blood
supply. Thus, isolated anterior pituitary insufficiency
occurs far more commonly than posterior insufficiency
as a complication of postpartum hemorrhage, with
diabetes insipidus occurring only 5% of the time.2
Our patient also had isolated anterior pituitary disease.
In line with advances in modern obstetrics, the
occurrence of Sheehan’s syndrome has declined
appreciably. Predisposing factors include multiple
gestation and malpositioning of the placenta, and
our patient was at risk of postpartum hemorrhage
because of placenta previa.
The diagnosis of Sheehan’s syndrome remains
difficult. A history of postpartum hemorrhage and the
subsequent appearance of hypopituitarism constitute
the main basis for clinical suspicion. Hypopituitarism
may range from mild to life-threatening, and may
involve single or multiple hormone deficiencies.
Acutely, patients may present with breast atrophy, lack
of lactation, fatigue, hypotension, and hypoglycemia,
with each hormone deficiency giving rise to a
characteristic picture. Corticotropin deficiency, for
example, results in weakness, fatigue, hypoglycemia,
and dizziness, whereas gonadotropin deficiency
manifests as amenorrhea, oligomenorrhea, hot flashes,
and decreased libido.
In our patient, the diagnosis of Sheehan’s syndrome
was corroborated by her history, lack of postpartum
lactation, and abnormal hormonal radioimmunoassays
and MRI findings. Hormone stimulation tests, in
particular the insulin hypoglycemic test, were not
conducted during hospitalization because of the
patient’s predisposition to seizure and arrhythmia and
because they would have provided limited clinical
information for acute management. Regrettably, for
personal reasons, the patient discontinued treatment
at our hospital soon after discharge, and we were
unable to perform follow-up stimulation tests.
According to published literature, stimulatory
testing for patients with Sheehan’s syndrome most
commonly reveals a lack of growth hormone (GH)
and prolactin responses to insulin-induced
hypoglycemia, or lack of a prolactin response to
stimulation with thyrotropin-releasing hormone
(TRH). A possible explanation might be the
sequestration of somatotrophs and lactotrophs in the
inferolateral aspects of the pituitary gland, which are
most susceptible to ischemic insult.3 Stimulation via
insulin-induced hypoglycemia is potentially hazardous
for elderly patients and those with impaired heart
function. Therefore, stimulation of prolactin release
with TRH, which is safer, faster, and more practical
than stimulation by insulin-induced hypoglycemia,
might be the favored approach for Sheehan’s syndrome
screening.4
The differential diagnoses of Sheehan’s syndrome
include lymphocytic hypophysitis and pituitary
hemorrhage or infarction secondary to overgrowth
of an adenoma. Clinical manifestations of these
conditions are similar, but imaging modalities such
as MRI should permit accurate differentiation. A
pre-existing adenoma may give rise to the appearance
of a deviated pituitary stalk, enlargement of the
sella turcica, or erosion of the floor of the sella.
Lymphocytic hypophysitis appears on MRI as a
symmetrically enlarged pituitary gland which is
contrast-enhanced by gadolinium diethylenetriamine
penta-acetic acid (Gd-DTPA). The pituitary gland in
Sheehan’s syndrome characteristically appears as a
high-intensity lesion on T2-weighted imaging, but
without contrast enhancement after Gd-DTPA. This
has been attributed to acute ischemia of the gland.5
Nonetheless, a history of postpartum hemorrhage
remains the cornerstone for the diagnosis of Sheehan’s
syndrome, with imaging studies playing only a
secondary diagnostic role.
There have been previous reports of hypopituitarism
associated with ECG abnormalities.6 Findings include
ST-segment depression, T-wave inversion, and QT-
interval prolongation, the reasons for which are
unknown, although Iga et al7 proposed a mechanism
based on hypoglycemia. Indeed, patients with
hypoadrenalism might be susceptible to hypoglycemia-
invoked catecholamine release, resulting in arrhyth-
mias or abnormal ventricular contractions. Other
researchers have suggested that hypomagnesemia
associated with adrenal insufficiency may contribute
to an electrical imbalance across the cardiac myocyte
membrane and, therefore, produce contractile
dysfunction. Our patient, however, did not develop
hypomagnesemia (serum magnesium, 1.8 mg/dL).
She had an initial random plasma glucose level of 197
mg/dL, which was measured when her condition was
critical. During hospitalization, she had only 1 episode
of hypoglycemia (59 mg/dL). Another possible cause
for her heart failure may have been fluid overload,
particularly as free water clearance is impaired in both
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hypothyroidism and hypoadrenalism. The increase in
our patient’s urine output after hormone replacement
supports this hypothesis.
Prolongation of the QT interval might trigger
the onset of polymorphic ventricular tachycardias
(PVTs). QT prolongation has many causes, including
drugs, electrolyte imbalance, myocardial disease,
cerebrovascular disease, and congenital long QT
syndrome. In addition, hypothyroidism may also
lengthen the QT interval.8 Our patient had multiple
episodes of PVTs, without associated electrolyte
abnormalities or the previous use of arrhythmogenic
drugs, although prolongation of the QT interval was
identified. After instituting hormone replacement, the
arrhythmias did not recur and the QT interval
normalized. Therefore, for patients with PVTs and a
prolonged QT interval, the possibility of endocrinologic
disorders should also be considered. Timely correction
of hormonal imbalances may prevent the development
of fatal arrhythmias.
The pathogenesis of acute Sheehan’s syndrome is
not entirely clear, although there is no doubt that the
basic process is infarction secondary to arrest of
blood flow to the pituitary gland. Nevertheless,
pituitary gland pathology in acute Sheehan’s
syndrome has rarely been reported. In 1 case report,
histologic examination revealed extensive acute
necrosis of the pituitary gland. In the necrotic area,
adenohypophyseal cells could not be recognized.
They had been replaced by ghost cells, necrotic
debris, coagulated blood, and inflammatory cells.9 In
the later phases of Sheehan’s syndrome, marked
shrinkage of the pituitary gland has been found,
together with massive fibrosis and the loss of
adenohypophyseal cells.
Acute presentation of Sheehan’s syndrome is rarely
described. There have been previous reports of acute
Sheehan’s syndrome presenting with either hypo-
glycemic coma or hyponatremia,10 but none with
acute heart failure as in the present case. The endocrine
diseases associated with heart failure include acro-
megaly, hypoparathyroidism, hypothyroidism, hyper-
thyroidism, and malignant carcinoid syndrome.11
There has been only 1 report of an adult patient with
pituitary hypoadrenalism complicated with
cardiomyopathy and heart failure; after appropriate
hormone replacement, cardiac contractile function
improved and heart failure resolved completely.12 In
our case, besides adrenal insufficiency and hypo-
thyroidism, tachyarrhythmia was also implicated in
the development of heart failure. Fortunately, prompt
hormone replacement improved and stabilized the
patient’s clinical course.
The treatment of Sheehan’s syndrome consists of
correction of hormone deficiencies. Acutely, corti-
costeroid therapy should be administered, followed
by thyroxine and estrogen replacement (the presence
of an intact uterus also necessitates progestin
replacement). For GH deficiency, adult GH
replacement therapy remains controversial.13 Several
reports have demonstrated beneficial effects of GH on
body composition (reduction of body fat and
augmentation of lean body mass), blood lipid profile,
and cardiovascular risk.14 However, an impact of GH
on quality of life has not been shown consistently:
Gilchrist et al15 reported improved life quality among
patients treated with GH for up to 9 years, whereas
Hoffman et al,16 in a double-blind, controlled trial,
found no benefit for GH on exercise tolerance or
quality of life.
In summary, Sheehan’s syndrome is rarely en-
countered. It is even more unusual for it to manifest
in the weeks immediately after delivery. Nevertheless,
the index of suspicion is raised when a patient presents
with a history of massive postpartum hemorrhage
complicated with shock, and clearly, clinicians should
be mindful of the clinical picture of Sheehan’s syndrome.
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